Bioanalytical Method Validation (LC-MS/MS & Chromatographic Methods)

Dilution Integrity and Carryover Assessment in LC-MS/MS Assays

Dilution Integrity and Carryover Assessment in LC-MS/MS Assays Dilution Integrity and Carryover Assessment in LC-MS/MS Assays The assessment of dilution integrity and carryover in LC-MS/MS assays is an essential component of bioanalytical method validation, particularly in the pharmaceutical industry. Ensuring that high concentration samples do not adversely impact the integrity of diluted samples is critical for accurate and reliable bioanalysis….

Continue Reading Dilution Integrity and Carryover Assessment in LC-MS/MS Assays

Calibration Curve, Accuracy and Precision in Bioanalytical Method Validation

Calibration Curve, Accuracy and Precision in Bioanalytical Method Validation Bioanalytical method validation is a critical aspect of ensuring the reliability and accuracy of quantitative measurements in pharmaceutical research and development. The calibration curve plays a crucial role in this validation process, providing a graphical representation of the relationship between the concentration of an analyte and the detector response. This article…

Continue Reading Calibration Curve, Accuracy and Precision in Bioanalytical Method Validation

Selectivity and Matrix Effect Studies in LC-MS/MS Bioanalytical Method Validation

Selectivity and Matrix Effect Studies in LC-MS/MS Bioanalytical Method Validation In the realm of pharmaceutical development, ensuring the reliability of bioanalytical methods is paramount. One critical aspect of this reliability hinges on understanding the concepts of selectivity and matrix effects in bioanalysis. This article serves as an extensive regulatory-style manual designed for professionals involved in analytical and bioanalytical method validation,…

Continue Reading Selectivity and Matrix Effect Studies in LC-MS/MS Bioanalytical Method Validation

FDA and EMA Bioanalytical Method Validation Requirements for LC-MS/MS Assays

FDA and EMA Bioanalytical Method Validation Requirements for LC-MS/MS Assays Understanding FDA and EMA Bioanalytical Method Validation Requirements for LC-MS/MS Assays The validation of bioanalytical methods is a crucial component in ensuring the reliability and regulatory compliance of clinical studies. In this article, we will delve into the bioanalytical validation requirements set forth by the US FDA and the EMA,…

Continue Reading FDA and EMA Bioanalytical Method Validation Requirements for LC-MS/MS Assays

Incurred Sample Reanalysis (ISR) Requirements in Bioanalytical Method Validation

Incurred Sample Reanalysis (ISR) Requirements in Bioanalytical Method Validation The validation of bioanalytical methods is paramount in ensuring the reliability and accuracy of data used in pharmaceutical development and regulatory submissions. One key aspect of bioanalytical method validation is the requirement for incurred sample reanalysis (ISR), a critical approach that assesses the reproducibility of test results. This article delineates the…

Continue Reading Incurred Sample Reanalysis (ISR) Requirements in Bioanalytical Method Validation

Incurred Sample Reanalysis (ISR) Requirements in Bioanalytical Method Validation

Incurred Sample Reanalysis (ISR) Requirements in Bioanalytical Method Validation Incurred Sample Reanalysis (ISR) Requirements in Bioanalytical Method Validation Introduction to Incurred Sample Reanalysis (ISR) Incurred Sample Reanalysis (ISR) is an essential component of bioanalytical method validation, particularly in the context of pharmacokinetic (PK) studies. ISR serves to ensure the integrity and reliability of assay results that are crucial for drug…

Continue Reading Incurred Sample Reanalysis (ISR) Requirements in Bioanalytical Method Validation

Handling Hemolysed and Lipemic Samples in LC-MS/MS Bioanalytical Validations

Handling Hemolysed and Lipemic Samples in LC-MS/MS Bioanalytical Validations Handling Hemolysed and Lipemic Samples in LC-MS/MS Bioanalytical Validations In the pharmaceutical and bioanalytical field, the integrity of sample collections significantly impacts the reliability of outcome data. This tutorial aims to provide a comprehensive step-by-step guide for professionals handling challenging sample matrices, specifically hemolysed and lipemic samples in LC-MS/MS bioanalytical validations….

Continue Reading Handling Hemolysed and Lipemic Samples in LC-MS/MS Bioanalytical Validations

Handling Hemolysed and Lipemic Samples in LC-MS/MS Bioanalytical Validations

Handling Hemolysed and Lipemic Samples in LC-MS/MS Bioanalytical Validations In the realm of bioanalytical method validation, capturing and analyzing challenging sample matrices such as hemolysed and lipemic samples is critical for ensuring data integrity and regulatory compliance. This step-by-step tutorial provides a comprehensive guide for pharmaceutical and regulatory professionals on how to manage these complex matrices effectively in LC-MS/MS assays….

Continue Reading Handling Hemolysed and Lipemic Samples in LC-MS/MS Bioanalytical Validations

Partial Validation and Cross-Validation of Bioanalytical Methods Across Sites

Partial Validation and Cross-Validation of Bioanalytical Methods Across Sites Partial Validation and Cross-Validation of Bioanalytical Methods Across Sites Pharmaceutical validation plays a crucial role in ensuring the accuracy and reliability of bioanalytical methods, particularly in the context of changing sites or conditions. This article provides a detailed regulatory explainer manual on the expectations surrounding partial validation and cross-validation. Specific guidance…

Continue Reading Partial Validation and Cross-Validation of Bioanalytical Methods Across Sites

Validating Ligand Binding and Chromatographic Methods for PK and Immunogenicity

Validating Ligand Binding and Chromatographic Methods for PK and Immunogenicity Validating Ligand Binding and Chromatographic Methods for PK and Immunogenicity The validation of bioanalytical methods, particularly ligand binding assays and chromatographic techniques, is critical in pharmaceutical development to ensure reliability in pharmacokinetic (PK) studies and the assessment of immunogenicity. Regulatory bodies such as the US FDA, EMA, and MHRA have…

Continue Reading Validating Ligand Binding and Chromatographic Methods for PK and Immunogenicity